Navigation Links
MarketResearchReports.Biz: Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma And Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019 - New Industry Report

ALBANY, New York, September 12, 2013 /PRNewswire/ --

New Market Research Report Added in MarketResearchReports.Biz Reports Database Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

This report studies the global market for companion diagnostics from two perspectives - companion diagnostics by indication and by geography. The market for companion diagnostics by indication includes sub-segments such as breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma and others (HIV, Thalassemia). By geography, the companion diagnostics market has been divided into four regions, namely, North America, Europe, Asia-Pacific and RoW. Market size and forecast for each segment and sub-segment has been provided for the period 2011 to 2019 in terms of USD million, with 2012 as the base year. The compounded annual growth rate (CAGR) for each market segment has been provided for the forecast period (2013 to 2019).

The report also contains a section on market overview which consists of a detailed qualitative analysis of various market dynamics, such as drivers, restraints and opportunities. A section on market attractiveness analysis and Porter's five force analysis for the companion diagnostics market has also been included.

To Download Detail Report Click Here:

Market share analysis of the leading players operating in the companion diagnostics market, in terms of % share for the year 2012, has been presented in the competitive landscape. The report also includes the list of recommendations for new market entrants. Some of the key market players profiled in this report include Roche Holdings AG, Abbott Laboratories, Genomic Health, Inc., Qiagen N.V., Life Technologies Corporation, Agilent Technologies, Inc. and GE Healthcare, Ltd.

The global companion diagnostics market is segmented into the following categories:

Companion Diagnostics Market, by Indications

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Other (HIV, Thalassemia)

Companion Diagnostics Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

TO Read the complete Report with TOC @:

Table of Contents

Chapter 1 Introduction

1.1 Report Description

1.2 Research Methodology

1.3 Market Segmentation

1.4 List Of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Market Overview

3.1 Introduction

3.2 Market Drivers

3.2.1 Rising Need For Companion Diagnostics Along With Targeted Therapies

3.2.2 Increasing Demand As Well As Developmental Efforts Towards Personalized Medicine

3.2.3 The Pharmacoeconomic Advantage: Reduced Drug Development Costs

3.2.4 Increasing Cancer Incidence Worldwide

3.2.5 Impact Analysis Of Market Drivers

3.3 Market Restraints

3.3.1 Effect Of Influence Of Advocacy Groups And Clinical Societies

3.3.2 Prolonged Developmental And Approval Phases

3.3.3 Impact Analysis Of Market Restraints

3.4 Market Opportunities

3.4.1 Expansion Into Newer Indication Areas

3.5 Porter's Five Force Analysis: Global Companion Diagnostics Market

3.5.1 Bargaining Power Of Buyers

3.5.2 Bargaining Power Of Suppliers

3.5.3 Threat Of Substitutes

3.5.4 Threat Of New Entrants

3.5.5 Competitive Rivalry

3.6 Market Attractiveness Analysis: Global Companion Diagnostics Market, By Geography, 2012

Chapter 4 Companion Diagnostics Market, By Indications, 2011 - 2019 (USD Million)

4.1 Introduction

4.1.1 Comparative Analysis: Global Companion Diagnostics Market, By Indication, 2012 & 2019 (Value %)

4.1.2 Breast Cancer

4.1.3 Lung Cancer

4.1.4 Colorectal Cancer

4.1.5 Gastric Cancer

4.1.6 Melanoma

4.1.7 Others (HIV, Thalassemia)

Chapter 5 Companion Diagnostics Market, By Geography, 2011 - 2019 (USD Million)

5.1 Overview

5.1.1 Comparative Analysis: Global Companion Diagnostics Market, By Geography, 2012 & 2019 (Value %)

5.2 North America

5.2.1 North America Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)

5.3 Europe

5.3.1 Europe Companion Diagnostics Market Size And Forecast, 2011 - 2019 (Usd Million)

5.4 Asia-Pacific

5.4.1 Asia-Pacific Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)

5.5 Rest Of The World (Row)

5.5.1 Row Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)

Chapter 6 Competitive Landscape

6.1 Market Share By Key Players, 2012 (%)

Chapter 7 Recommendations

7.1 Changing Business Models of Pharmaceutical and Diagnostics Manufacturers

7.2 Investing in Emerging Economies

Chapter 8 Company Profiles

8.1 Abbott Laboratories

8.1.1 Company Overview

8.1.2 Financial Overview

8.1.3 Product Portfolio

8.1.4 Business Strategies

8.1.5 Recent Developments

8.2 Agendia N.V.

8.2.1 Company Overview

8.2.2 Product Portfolio

8.2.3 Business Strategies

8.2.4 Recent Developments

8.3 Agilent Technologies, Inc.,

8.3.1 Company Overview

8.3.2 Financial Overview

8.3.3 Product Portfolio

8.3.4 Business Strategies

8.3.5 Recent Developments

8.4 Biogenex Laboratories, Inc.

8.4.1 Company Overview

8.4.2 Product Portfolio

8.4.3 Business Strategies

8.4.4 Recent Developments

8.5 Ge Healthcare Ltd.

8.5.1 Company Overview

8.5.2 Financial Overview

8.5.3 Product Portfolio

8.5.4 Business Strategies

8.5.5 Recent Developments

8.6 Genomic Health, Inc.

8.6.1 Company Overview

8.6.2 Financial Overview

8.6.3 Product Portfolio

8.6.4 Business Strategies

8.6.5 Recent Developments

8.7 Laboratory Corporation Of America Holdings (Labcorp)

8.7.1 Company Overview

8.7.2 Financial Overview

8.7.3 Product Portfolio

8.7.4 Business Strategies

8.7.5 Recent Developments

8.8 Life Technologies Corporation

8.8.1 Company Overview

8.8.2 Financial Overview

8.8.3 Product Portfolio

8.8.4 Business Strategies

8.8.5 Recent Developments

8.9 Qiagen N.V.

8.9.1 Company Overview

8.9.2 Financial Overview

8.9.3 Product Portfolio

8.9.4 Business Strategies

8.9.5 Recent Developments

8.10 Resonance Health Analysis Services Pty Ltd.

8.10.1 Company Overview

8.10.2 Product Portfolio

8.10.3 Business Strategies

8.10.4 Recent Developments

8.11 Roche Holdings Ag

8.11.1 Company Overview

8.11.2 Financial Overview

8.11.3 Product Portfolio

8.11.4 Business Strategies

8.11.5 Recent Developments

8.12 Siemens Healthcare

8.12.1 Company Overview

8.12.2 Financial Overview

8.12.3 Product Portfolio

8.12.4 Business Strategies

8.12.5 Recent Developments

Related Reports @ :

Global Cardiovascular Monitoring & Diagnostic Devices Market (2011 - 2016)

This report analyses the Cardiovascular Monitoring and Diagnostic devices into four sub- categories, which includes. ECG monitoring equipment is used to record the Electrocardiogram, ECG which are the intrinsic electrical signals generated in the heart.

Browse Complete Report With TOC @:

Global Diabetes Devices & Drugs Market (2011- 2016)

The report contains the global scenario of Diabetes market discussing its details and market figures. The report provides market size and forecast till 2016 for each segment and geography across the globe. It also describes the key influencing factors for Diabetes market. The report lists mergers & acquisitions among the major players along with key product developments in the market.

Browse Complete Report With TOC @:

Prostate Cancer Minimally Invasive Surgery Market In North America And Europe (2011 - 2016)

Objective of the Study To analyze, estimate and forecast the minimally invasive surgical devices market for treating prostate cancer To identify the drivers, restraints and opportunities for the prostate cancer minimally invasive market To identify the trend, burning issues, winning imperatives and growth prospects for the prostate cancer minimally invasive market To identify the major market players and determine their respective market share, core competencies

Browse Complete Report With TOC @:

Latest Reports @ :

Metrology Services Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018


MEMS In Medical Applications Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019


Household Vacuum Cleaners Market - Global Industry Analysis, Size, Share And Forecasts, 2012 - 2018


About Us is the most comprehensive collection of market research reports. services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-997-4948
Site :
Blog @ :

SOURCE MarketResearchReports.Biz
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Companion Diagnostics Market is Expected to Reach USD 5.6 Billion Globally in 2019: Transparency Market Research
2. Personalized Medicine Makes Its Way to Pets With Cancer: Morphogenesis and SEVO-Med Team up for a Canine Cancer Field Study, First of Its Kind, Side-Effect-Free Process to Treat Companion Animals
3. Life Technologies to Collaborate with Merck Serono for Companion Diagnostics Development and Commercialization
4. Medical Design Excellence Awards Selects Companion 2 Hospital Driver for Powering SynCardia Total Artificial Heart as Silver Winner
5. Empire Genomics Awarded SBIR Phase I Grant from NCI for Companion Diagnostics for Multiple Myeloma
6. Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
7. Market Access Expert Firm, PRMA Consulting, Launches Companion Diagnostics Handbook
8. PrimeraDx to Co-Develop Companion Diagnostics with Quest Diagnostics
9. Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
10. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
11. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
Post Your Comments:
(Date:11/25/2015)... QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ ... "Company"), affirms that its business and prospects remain ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB ... program to completion following review of the final ... met Phase 2 Primary Endpoint in men with ...
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... The United ... recipient of the 2016 USGA Green Section Award. Presented annually since 1961, the USGA ... his or her work with turfgrass. , Clarke, of Iselin, N.J., is ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
Breaking Biology Technology:
(Date:11/17/2015)... 17, 2015  Vigilant Solutions announces today that Mr. ... of Directors. --> --> ... from the partnership at TPG Capital, one of the ... $140 Billion in revenue.  He founded and led TPG,s ... TPG companies, from 1997 to 2013.  In his first ...
(Date:11/12/2015)... CAMBRIDGE, Mass. , Nov. 12, 2015 /PRNewswire/ ... Broad Institute of MIT and Harvard for use ... chemical discovery information management tools. The partnership will ... share both biological and chemical research information internally ... tools will be used for managing the Institute,s ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
Breaking Biology News(10 mins):